ArticleOncoTargets and therapy2020

A Novel Imidazopyridine Derivative Exhibits Anticancer Activity in Breast Cancer by Inhibiting Wnt/β‑catenin Signaling.

Liu-Jun He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.